Buscador de Revistas

Doklady Chemistry is a journal containing English translations of current Russian research in chemistry and chemical technology from the chemistry and chemical technology sections of the Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times a year; the articles from the chemistry and chemical technology sections are collected, translated, and published in 12 issues a year. Doklady Chemistry publishes the most significant new chemistry and chemical technology research being done in Russia today thus ensuring its scientific priority. The journal presents theoretical and experimental research on all branches of chemical science including organic, organoelement, inorganic, macromolecular, coordination, and analytical chemistry as well as short accounts of all aspects of experimental and theoretical chemical engineering. The journal is intended for scientists in all fields of chemistry and in interdisciplinary sciences. The Editorial Board of Doklady Akademii Nauk

Doklady Earth Sciences is a journal of the Presidium of the Russian Academy of Sciences. It contains English translations of papers published in Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences), which was founded in 1933 and is published 36 times a year. Doklady Earth Sciences includes materials from the following areas: geology, mineralogy, petrology, oceanology, geography, soil science, paleontology, geochemistry, and geophysics.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting Russian or foreign members of the Russian Academy of Sciences.

Doklady Mathematics is a journal of the Presidium of the Russian Academy of Sciences. It publishes brief, scientific reports on previously unpublished significant new research in mathematics and its applications, including mathematical physics, computer science, control theory, and computers. The main contributors to the journal include members of the Russian Academy of Sciences (RAS), corresponding members of the RAS, and scientists from the former Soviet Union and other foreign countries. Among the contributors are the outstanding Russian mathematicians V.I. Arnol´d, N.S. Bakhvalov, S.V.Emel´anov, Yu.L. Ershov, A.T. Fomenko, I.M. Gel´fand, V.A. Il´in, A.A. Krasovskii, M.M. Lavrent´ev, V.P. Maslov, S.M. Nikol´skii, O.A. Oleinik, Yu.G. Reshetniak, A.A. Samarskii, and V.S. Vladimirov. Doklady Mathematics contains English translations of papers published in Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences), which was founded in 1933.

Doklady Physical Chemistry is a monthly journal containing English translations of current Russian research in physical chemistry from the Physical Chemistry sections of the Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The journal publishes the most significant new research in physical chemistry being done in Russia, thus ensuring its scientific priority. Doklady Physical Chemistry presents short preliminary accounts of the application of the state-of-the-art physical chemistry ideas and methods to the study of organic and inorganic compounds and macromolecules; polymeric, inorganic and composite materials as well as corresponding processes. The journal is intended for scientists in all fields of chemistry and in interdisciplinary sciences.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting

Doklady Physics is a monthly journal containing English translations of current Russian research in physics, technical physics, astronomy, and mechanics from Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times a year; the physics sections are collected, translated, and published in 12 issues a year. Doklady Physics publishes the most significant new research in physics being done in Russia today, thus ensuring its scientific priority.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting Russian or foreign members of the Russian Academy of Sciences.

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions. Research focused on the following areas of translational drug delivery research will be considered for publication in the journal. Designing and developing novel drug delivery systems, with a focus on their application to disease conditions: Preclinical and clinical data related to drug delivery systems: Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes Short-term and long-term biocompatibility of drug delivery systems, host response: Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering: Image-guided drug therapy, Nanomedicine: Devices for drug delivery and drug/device combination products. In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes:   

• Overviews of contentious or emerging issues. 
• Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. 
• In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. 
• Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
• Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.
• Editorials and commentaries on topical issues.

Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 50 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original clinical research authored by leading international clinicians and researchers to support clinical decision-making.   

Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

As a hybrid journal, Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

For 30 years Drugs & Aging has been delivering essential information on the most important aspects of drug therapy to researchers and healthcare professionals involved in the care of older patients.

Through a program of reviews and original research articles, the journal addresses major issues relating to drug therapy in older adults, including the management of specific diseases or disorders, particularly those associated with aging, age-related physiological changes impacting drug therapy, and issues related to drug utilization and prescribing.

As a hybrid journal, Drugs & Aging does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).

Drugs & Aging offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).

Drugs & Therapy Perspectives provides concise, authoritative review articles to aid drug formulary and prescribing decisions. It is a digest of the latest drug knowledge covering the most important aspects of clinical therapeutics, including:Questions and answers on the clinical use of drugs.Comparisons of the features of various drugs, using differential feature tables.Current thinking on disease management.Step-by-step clinical decision-making, illustrated with patient care algorithms.First reports of serious adverse drug reactions.Clinically useful pharmacodynamics and pharmacokinetics.Developments in pharmacoeconomics and other research that have a bearing on clinical practice.All material is prepared by Adis editors and medical writers, unless otherwise noted. The preparation of material is not supported by any external funding. All review articles are subject to peer review by members of the journal's international editorial board and/or other experts.

Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs in R&D is an international, peer reviewed, open access, online only journal, which provides timely information on emerging drug classes and new treatments for specific disorders in an ‘open access’ format for all to review. Original research and reviews from all phases of clinical development are included, with a strong link to clinical practice. Healthcare decision makers are thus provided with clinically applicable knowledge about the likely place in therapy of a drug.Journal issues comprise:·        Original research on new drugs, including clinical trials:·        New research on established drugs.·        R&D Insight reports:Short communications and letters to the editor are welcomed and will be considered for publication. Reviews may also be considered. All manuscripts are subject to peer review by international experts.

Dynamic Games and Applications is devoted to the development of all classes of dynamic games, namely, differential games, discrete-time dynamic games, evolutionary games, repeated and stochastic games, and their applications in all fields, including:* biology:* computer science:* ecology:* economics:* engineering:* management science:* operations research:* political science:* psychology. DGAA seeks original research that makes significant methodological, conceptual, algorithmic, or empirical contributions to various disciplines. DGAA also considers work in static game theory and dynamic optimization provided that authors establish a clear, potential link to dynamic games. DGAA publishes regular papers, technical notes, survey articles, and case studies.All submissions should be original in nature. During the peer review process, to promote scientific honesty and high standards, submitted manuscripts go through one or more revision stages leading up to acceptance or rejection.  Each paper is reviewed by at least two experts in the field.

Dysphagia is a multidisciplinary journal devoted to swallowing and its disorders. The journal's purpose is to provide an international source of information to physicians and other health professionals interested in this emerging field. Its scope includes all aspects of normal and dysphagic ingestion involving the mouth, pharynx, and esophagus. Accordingly, the journal will draw on expertise from a variety of disciplines including gastroenterology, neurology, otolaryngology, radiology, dentistry, rehabilitation medicine, speech pathology, nursing, dietetics, medical administration, and the basic biomedical sciences. The journal is intended to contribute to the development of this field by fostering communication between interested professionals, by setting forth existing knowledge, and by stimulating further research. Submission of contributions that advance the understanding of normal swallowing as well as those related to dysphagia, its diagnosis, and its clinical management, is encouraged. Dysphagia has be